UK MHRA sets up new forum to tackle growing threat from counterfeit devices
This article was originally published in Clinica
Executive Summary
The UK’s Medicines and Healthcare products Regulatory Agency is establishing a permanent stakeholder group to highlight current trends and threats to UK patients from counterfeit devices.